MX2020007069A - Preparación de barrera para la piel y método para esta. - Google Patents

Preparación de barrera para la piel y método para esta.

Info

Publication number
MX2020007069A
MX2020007069A MX2020007069A MX2020007069A MX2020007069A MX 2020007069 A MX2020007069 A MX 2020007069A MX 2020007069 A MX2020007069 A MX 2020007069A MX 2020007069 A MX2020007069 A MX 2020007069A MX 2020007069 A MX2020007069 A MX 2020007069A
Authority
MX
Mexico
Prior art keywords
method therefor
surfactant preparation
mild surfactant
mild
preparation
Prior art date
Application number
MX2020007069A
Other languages
English (en)
Inventor
Thierry Oddos
Jalil Bensaci
Georgios N Stamatas
Original Assignee
Johnson & Johnson Consumer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer Inc filed Critical Johnson & Johnson Consumer Inc
Publication of MX2020007069A publication Critical patent/MX2020007069A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0004Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0006Skin tests, e.g. intradermal testing, test strips, delayed hypersensitivity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01JMEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
    • G01J3/00Spectrometry; Spectrophotometry; Monochromators; Measuring colours
    • G01J3/28Investigating the spectrum
    • G01J3/44Raman spectrometry; Scattering spectrometry ; Fluorescence spectrometry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/0078Testing material properties on manufactured objects
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082Supracellular entities, e.g. tissue, organisms
    • G01N33/5088Supracellular entities, e.g. tissue, organisms of vertebrates
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06FELECTRIC DIGITAL DATA PROCESSING
    • G06F16/00Information retrieval; Database structures therefor; File system structures therefor
    • G06F16/20Information retrieval; Database structures therefor; File system structures therefor of structured data, e.g. relational data
    • G06F16/24Querying
    • G06F16/245Query processing
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06FELECTRIC DIGITAL DATA PROCESSING
    • G06F30/00Computer-aided design [CAD]
    • G06F30/20Design optimisation, verification or simulation
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01JMEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
    • G01J3/00Spectrometry; Spectrophotometry; Monochromators; Measuring colours
    • G01J3/28Investigating the spectrum
    • G01J2003/2866Markers; Calibrating of scan

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Pathology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Medical Informatics (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Theoretical Computer Science (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Primary Health Care (AREA)
  • General Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)

Abstract

Se describe un método para seleccionar un sistema de barrera para la piel adecuado para infantes y niños pequeños.
MX2020007069A 2018-01-05 2018-12-14 Preparación de barrera para la piel y método para esta. MX2020007069A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862613878P 2018-01-05 2018-01-05
PCT/IB2018/060128 WO2019135128A1 (en) 2018-01-05 2018-12-14 Mild surfactant preparation and method therefor

Publications (1)

Publication Number Publication Date
MX2020007069A true MX2020007069A (es) 2021-01-15

Family

ID=65365985

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2020007069A MX2020007069A (es) 2018-01-05 2018-12-14 Preparación de barrera para la piel y método para esta.
MX2020007064A MX2020007064A (es) 2018-01-05 2018-12-14 Preparacion de barrera para la piel y metodo para esta.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2020007064A MX2020007064A (es) 2018-01-05 2018-12-14 Preparacion de barrera para la piel y metodo para esta.

Country Status (11)

Country Link
US (2) US11090393B2 (es)
EP (2) EP3735700A1 (es)
JP (2) JP7317838B2 (es)
KR (1) KR102697021B1 (es)
CN (2) CN111566754B (es)
AU (2) AU2018399218B2 (es)
BR (2) BR112020013593A8 (es)
CA (2) CA3086656A1 (es)
MX (2) MX2020007069A (es)
WO (2) WO2019135128A1 (es)
ZA (1) ZA202004823B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11229595B2 (en) * 2019-05-29 2022-01-25 Johnson & Johnson Consumer Inc. Skin barrier preparation and method therefor
JP7309765B2 (ja) * 2021-03-04 2023-07-18 花王株式会社 経皮吸収量の推定方法
EP4402644A1 (en) 2021-09-16 2024-07-24 Johnson & Johnson Consumer Inc. Analysis and characterization of epithelial tissue structure
KR20240138109A (ko) 2022-01-28 2024-09-20 존슨 앤드 존슨 컨수머 인코포레이티드 아토피성 피부염을 예측하는 바이오마커
WO2023194839A1 (en) 2022-04-04 2023-10-12 Donnelly Window of opportunity skin treatment regimen and composition for preventing the onset of or treating atopic dermatitis

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69735354T2 (de) * 1996-10-28 2006-11-30 Amersham Health As Verbesserungen an oder in verbindung mit diagnostischen/therapeutischen verbindungen
US6151717A (en) 1999-07-20 2000-11-28 Aearo Company Transparent or translucent earmuff cup
WO2001053444A1 (en) 2000-01-20 2001-07-26 The Procter & Gamble Company Antimicrobial compositions
CN1506042A (zh) * 2002-12-11 2004-06-23 苏加璐 使用来自胎儿细胞和组织的化合物改善皮肤状况的方法和组合物
US20070238941A1 (en) * 2006-03-28 2007-10-11 Janeta Nikolovski Methods and devices for evaluating skin
JP5608282B2 (ja) * 2010-04-05 2014-10-15 イー・エム・デイー・ミリポア・コーポレイシヨン ヒト皮膚様透過性を有するポリマー膜およびこの使用
JP5946699B2 (ja) * 2012-06-01 2016-07-06 花王株式会社 水分透過バリア機能の評価方法
FR2993282B1 (fr) * 2012-07-13 2017-11-10 Expanscience Lab Procede d'identification de marqueurs moleculaires de la peau d'enfant
WO2014028569A1 (en) 2012-08-15 2014-02-20 The Procter & Gamble Company Systems, models and methods for identifying and evaluating skin-active agents effective for treating an array of skin disorders
US9256963B2 (en) * 2013-04-09 2016-02-09 Elc Management Llc Skin diagnostic and image processing systems, apparatus and articles
JP6147608B2 (ja) 2013-08-20 2017-06-14 日本メナード化粧品株式会社 X線回折を利用した皮膚浸透性評価法
CN103785064B (zh) * 2013-08-26 2015-02-25 济南磐升生物技术有限公司 一种皮肤模型及应用
FR3019186B1 (fr) * 2014-03-31 2019-06-07 Laboratoires Expanscience Procedes d'evaluation des effets deleteres de l'urine sur la peau d'enfant
CN104376221B (zh) * 2014-11-21 2018-06-15 环境保护部南京环境科学研究所 一种预测有机化学品的皮肤渗透系数的方法
FR3045669B1 (fr) 2015-12-16 2019-04-05 Laboratoires Expanscience Procedes d'evaluation des effets de la deshydratation sur la peau d'enfant
US20180185255A1 (en) 2017-01-05 2018-07-05 The Procter & Gamble Company Method of Selecting Mild Skin Cleansers
EP3370178A3 (en) * 2017-03-03 2018-12-19 Tata Consultancy Services Limited Method and system for in silico testing of actives on human skin

Also Published As

Publication number Publication date
JP2021509954A (ja) 2021-04-08
EP3735701A1 (en) 2020-11-11
US11744905B2 (en) 2023-09-05
CA3086684A1 (en) 2019-07-11
CN111602207B (zh) 2024-10-01
CN111566754A (zh) 2020-08-21
AU2018399218A1 (en) 2020-07-02
JP7314148B2 (ja) 2023-07-25
BR112020013544A2 (pt) 2020-12-01
RU2020125674A3 (es) 2022-02-07
AU2018399218B2 (en) 2024-02-22
AU2018399217B2 (en) 2024-09-26
RU2020125673A3 (es) 2022-04-29
RU2020125673A (ru) 2022-02-07
BR112020013593A2 (pt) 2020-12-01
CN111602207A (zh) 2020-08-28
WO2019135129A1 (en) 2019-07-11
JP2021510199A (ja) 2021-04-15
KR102697021B1 (ko) 2024-08-22
ZA202004823B (en) 2023-05-31
AU2018399217A1 (en) 2020-07-09
KR20200106919A (ko) 2020-09-15
CN111566754B (zh) 2024-08-30
US20190212324A1 (en) 2019-07-11
US20190209711A1 (en) 2019-07-11
WO2019135128A1 (en) 2019-07-11
KR20200106519A (ko) 2020-09-14
RU2020125674A (ru) 2022-02-07
BR112020013544A8 (pt) 2022-07-26
MX2020007064A (es) 2020-09-09
BR112020013593A8 (pt) 2022-07-26
US11090393B2 (en) 2021-08-17
CA3086656A1 (en) 2019-07-11
JP7317838B2 (ja) 2023-07-31
EP3735700A1 (en) 2020-11-11

Similar Documents

Publication Publication Date Title
MX2020007069A (es) Preparación de barrera para la piel y método para esta.
TWI799439B (zh) 對劣化電路的輸出進行模擬的電路模擬器、方法和系統
MX2017016900A (es) Método y aparato para el soporte extracorpóreo del feto prematuro.
EP3427704A4 (en) MOUTHPIECE, SHEET FOR PRODUCING PART OF THE PIECE FOR MOUTHPIECE, AND METHOD FOR PRODUCING SAID MOUTHPIECE
MX2015008986A (es) Replica de queso no lacteo que comprende un coacervado.
MY180379A (en) Power control of device-to-device synchronization signal
EP3494548A4 (en) SYSTEM AND METHOD FOR GENERATING AND UPDATING A THREE-DIMENSIONAL LUMINAL NETWORK MODEL
MX2021014570A (es) Método para seleccionar un sistema de barrera para la piel adecuado para infantes y niños pequeños.
PT3768879T (pt) Sistema e método para geração de gases
GEP20217231B (en) Methods for treatment and prophylaxis of hiv and aids
CR20210158A (es) Formas de dosificación pediátricas de vitamina d, métodos de elaboración y uso
MY190449A (en) Method and apparatuses for operating a wireless communication network
PH12018502672A1 (en) Method for increasing nitrogen-use efficiency and or nitrogen-utilisation efficiency in plants
JP1713681S (ja) 着用型乳児抱っこひも
PL3665603T3 (pl) Sposób i urządzenie do natychmiastowego i pozbawionego sprzężenia zwrotnego przesyłania komunikatów z dziennika
EP3680324A4 (en) STEM CELLS FROM A YOUNG PIG AND METHOD OF MANUFACTURING THEREFORE
ZA202104083B (en) Viral inactivation methods for continuous manufacturing of antibodies
CA161830S (en) Bacon strips teething toy for infant
GB2576419B (en) Infant highchair
SG10201910692SA (en) Photomask blank, and method of manufacturing photomask
MY182011A (en) Devices and kits for production of personalized, concentrated human milk compositions, and methods of making and using same
GB2593175B (en) An infant chair
AU2018903493A0 (en) Infant swaddling system and components thereof
AU201815559S (en) Baby Carriage
EP3898959A4 (en) PHOSPHORYLATED DICER ANTIBODY AND METHODS OF USE THEREOF